Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-01-06 @ 6:46 AM
Study NCT ID:
NCT03639467
Status:
UNKNOWN
Last Update Posted:
2018-09-18
First Post:
2018-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma
Sponsor:
Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-08-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-08-15
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-15
First Submit QC Date:
None
Study First Post Date:
2018-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-17
Last Update Post Date:
2018-09-18
Last Update Post Date Type:
ACTUAL